We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
96 hedge funds and large institutions have $146M invested in scPharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
62% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 13
47% more capital invested
Capital invested by funds: $98.7M → $146M (+$46.8M)
9% more funds holding
Funds holding: 88 → 96 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 32
2.32% less ownership
Funds ownership: 74.67% → 72.35% (-2.3%)
Holders
96
Holders Change
+8
Holders Change %
+9.09%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
30
Reduced
32
Closed
13
Calls
$4.21M
Puts
–
Net Calls
+$4.21M
Net Calls Change
+$3.83M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.64M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.56M |
| 3 |
Millennium Management
New York
|
+$1.41M |
| 4 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
+$1.3M |
| 5 |
Morgan Stanley
New York
|
+$813K |
